The most useful paragraph in a junior mining press release is often the one under “Corporate Update,” near the bottom. ICG Silver & Gold’s release on September 30 opened with 24.3 meters of 10.14 g/t gold and closed with a US$150,000 payment for three months of investor awareness services. Connect Biopharma hit its primary endpoint in COPD the same day, and Sangoma Technologies agreed to sell itself at a 47% premium two days earlier.
Mining & Minerals
ICG Silver & Gold Drills 24.3 Meters of 10.14 g/t Gold at Battle Mountain
ICG Silver & Gold (CSE: ICG, OTC Pink: ICGSF) reported assays September 30 from the first six of 12 reverse-circulation holes in its 2026 Phase 1 program at the Tuscarora District in Elko County, Nevada. Hole T26RC-04 at the Battle Mountain target returned 24.3 meters grading 10.14 g/t gold and 3.4 g/t silver from 181.4 meters downhole, including 4.6 meters at 51.84 g/t gold and a single 1.5 meter sample at 137.0 g/t gold.
Battle Mountain is ground the company staked earlier this year, and all three holes drilled there sit inside that new 100%-owned footprint. All six reported holes hit gold or silver. Assays from the other six, at King’s Vein and East Pediment, are still working through the lab. True widths have not been determined; every interval is a downhole length.
There is no mineral resource on Tuscarora yet. The company’s forward-looking statements point to an inaugural estimate in Q1 2027, and the historical sampling data shown in its figures has not been fully verified. The same release disclosed a US$150,000 payment to Emerging Markets Consulting for three months of investor awareness services starting September 29, one day before the assays went out. ICGSF closed up about 17% on September 30.
ICGSF trades on OTC Pink, a tier with lighter disclosure requirements than OTCQB or OTCQX. The company announced FINRA Form 211 clearance and DTC eligibility in August, but US investors should confirm their broker carries the ticker. Canadian filings sit on SEDAR+.
Biotech & Life Sciences
Connect Biopharma’s Rademikibart Cuts COPD Treatment Failure by 81%
Connect Biopharma (Nasdaq: CNTB) reported preliminary topline data September 30 from its Phase 2 Seabreeze STAT COPD study. The trial enrolled 159 adults in the middle of an acute COPD flare who also had type 2 inflammation, an allergic-type immune response identified here by a blood eosinophil count of at least 300 cells/μL. One injection of rademikibart on top of standard care reduced treatment failure through Week 4 by 81% versus placebo (p=0.0122), which was the primary endpoint.
Treatment failure covers death, a COPD hospital readmission, a return emergency or unscheduled visit, or needing to step up medication within 28 days. New moderate to severe exacerbations fell 85% (p=0.030), and emergency visits or hospital admissions for new exacerbations fell 100% (p=0.0137). Adverse events and serious adverse events were less frequent than on placebo.
Lung function is where the data gets thinner. FEV1 at Week 4 was 70 mL better than placebo with p=0.1607, which is not statistically significant. The study’s stated key secondary endpoint, post-bronchodilator FEV1 at Week 1 per the company’s Q2 update, does not appear in the topline release. Rademikibart is investigational and not approved by the FDA.
Shares closed up 11.9% on September 30 after trading as much as 96% higher intraday, per StockTitan’s tracking. Connect had $31.5 million in cash and short-term investments at June 30, guided to at least one year of runway from August 12, and lost $17.3 million in Q2 alone. The company plans to meet the FDA about a Phase 3 program; the September 30 release did not address how that program would be funded. Quarterly filings are on SEC EDGAR.
Tech & Innovation
Sangoma Agrees to US$204 Million Takeover by BRC Group Holdings
Sangoma Technologies (TSX: STC, Nasdaq: SANG) signed a definitive arrangement agreement on September 28 to be acquired by an affiliate of BRC Group Holdings, at an enterprise value of about US$204 million. Shareholders get US$4.925 in cash plus 0.04767 of a BRC share for each Sangoma share, an implied US$5.225 (C$7.40) that sits about 47% above Sangoma’s September 28 TSX close.
The deal came out of a strategic review Sangoma announced in May. Officers and directors holding about 27% of the shares have signed voting support agreements, and there is no financing condition. Roughly US$170 million goes out in cash and about US$10 million in BRC stock, leaving Sangoma holders with around 4% of BRC.
Closing needs two-thirds of votes cast at a special meeting, a separate majority-of-the-minority vote under MI 61-101, court approval, and regulatory sign-off. The court step exists because this is a plan of arrangement, the court-supervised process Canadian companies commonly use for takeovers. Because part of the consideration is BRC stock, the implied value moves with BRC’s share price. Sangoma owes a US$5,397,000 termination fee if it walks for a superior proposal that BRC declines to match.
Both companies expect closing no later than early 2027. The 6-K on SEC EDGAR carries the announcement, and the full arrangement agreement followed in a later filing.
Green Energy & Cleantech
Green Energy & Cleantech: What Moved the Sector This Week
Fuel cell stocks reversed a selloff on September 29. Bloom Energy closed 10.80% higher at $291.25 after the prior session’s drop, which 24/7 Wall St. tied to concerns about delays at Project Jupiter, a data center site Bloom is contracted to power. FuelCell Energy and Plug Power moved up with it. On-site power for AI data centers has been the main story behind Bloom’s run this year.
Lithium had the week’s harder news. Sigma Lithium halted all mining and processing at Grota do Cirilo in Brazil on October 1, two days after calling reports of a license suspension incorrect. A federal court had suspended the mine’s environmental licenses over whether a nearby protected Afro-Brazilian community should have been consulted, and Brazil’s mining agency separately ordered corrective work on a pit slope. In its October 1 release, Sigma said operations are paused pending a federal appeals court ruling and kept its 2027 guidance of 330,000 tonnes. No date has been given for that ruling.
Small and micro-cap clean energy listings produced no company news strong enough to stand on its own this week.
Crypto & Fintech
Crypto & Fintech: What Moved the Sector This Week
Bitcoin traded at about $86,680 on the morning of October 2, up from roughly $83,450 a day earlier and from $77,300 a month before. It was still about 28% below where it stood a year ago. Short liquidations, easing Treasury yields and a fresh $113,000 Citigroup target fed the move ahead of the September jobs report, and Bitcoin cleared $86,000 for the second time in about two weeks.
ETF money did less of the lifting than it did the week before. Spot Bitcoin ETFs took in roughly $2.4 billion in the week ended September 25, but daily flows shrank to $31.0 million on September 28 and $66.2 million on September 29, then turned to a $148.7 million outflow on September 30. September still closed with $2.65 billion in net inflows, the second-largest month since October 2025.
No small or micro-cap crypto or fintech company put out news this week that could carry its own section.
What to Watch Next
Six completed holes from King’s Vein and East Pediment are still pending, with results to follow once lab work, quality control and technical review are done. Follow-up drilling at Battle Mountain is the obvious next step, and the company is pointing to an inaugural resource estimate in Q1 2027.
Connect had $31.5 million at June 30 and guided to at least one year of runway from August 12. It plans to seek FDA alignment on a Phase 3 design next. Watch for both the FDA meeting outcome and any financing or partnership announcement, since the September 30 release addressed neither.
Sangoma shareholders need to approve the deal by two-thirds of votes cast plus a majority-of-the-minority vote, followed by court and regulatory approvals. Both companies expect closing no later than early 2027.
As of Sigma’s October 1 release, operations were paused while the company waits on a federal appeals court ruling, with no date given. The mining agency’s separate slope-repair order also has to be dealt with before a full restart.
Flows cooled sharply after the $2.4 billion week ended September 25, including a $148.7 million net outflow on September 30. October flow data will show whether September’s buying was a peak or a base.
Sources
- ICG Silver & Gold Intersects 24.3 Meters of 10.14 g/t Gold, Including 4.6 Meters of 51.84 g/t Gold and 10.2 g/t Silver, at the Tuscarora District, Nevada, Newsfile Corp, September 30, 2026
- ICG Silver & Gold Announces U.S. Trading Milestones, Including FINRA Clearance of Form 211 and DTC Eligibility, StockTitan, August 10, 2026
- Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart in COPD, GlobeNewswire via StockTitan, September 30, 2026
- Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update, GlobeNewswire via StockTitan, August 12, 2026
- Sangoma Technologies Corporation Enters into Definitive Agreement to be Acquired by BRC Group Holdings, Inc., Form 6-K Exhibit 99.1, SEC EDGAR, September 28, 2026
- Sangoma Technologies Arrangement Agreement, Form 6-K Exhibit 99.1, SEC EDGAR, 2026
- Bloom Energy Rallies 11% as Fuel Cell Selloff Reverses, 24/7 Wall St., September 29, 2026
- Bloom Energy Stock Surges 11% on Record Revenue and Higher 2026 Guidance, FX Leaders, September 30, 2026
- Brazil Court Order Shuts Sigma Lithium Mine, MINING.COM, October 1, 2026
- Sigma Lithium Announces Its Operations Temporarily Paused Awaiting Ruling by Federal Court of Appeals, Newsfile Corp, October 1, 2026
- Current Price of Bitcoin for Oct. 2, 2026, Fortune, October 2, 2026
- Bitcoin and Ethereum Prices Today, Friday, October 2, 2026, Yahoo Finance, October 2, 2026
- Bitcoin ETF Flow, Farside Investors, accessed October 3, 2026
- Spot Bitcoin ETFs Log $2.7 Billion in September Inflows, The Block, October 2, 2026
Editorial Disclosure
The Green Energy & Cleantech and Crypto & Fintech items in this article cover sector-wide activity; no specific company is the subject of coverage in either. Tickers discussed as company subjects in this article: ICG / ICGSF (ICG Silver & Gold), CNTB (Connect Biopharma), and STC / SANG (Sangoma Technologies). aktiego.com has received no compensation from any company, IR firm, or third party in connection with this coverage, and no aktiego.com staff member holds a position in any security named above. Press release dates and sources: ICG Silver & Gold, September 30, 2026, Newsfile Corp; Connect Biopharma, September 30, 2026, GlobeNewswire; Sangoma Technologies, September 28, 2026, filed on SEC EDGAR as Form 6-K. All companies named as subjects are under $500 million USD in market capitalization as of the dates referenced above. ICG Silver & Gold trades in the US on OTC Pink, a tier with limited disclosure requirements; readers should confirm availability with their broker. ICG Silver & Gold has no mineral resource estimate under NI 43-101 (National Instrument 43-101, the Canadian standard governing public disclosure of mineral project information) on the Tuscarora District, true widths of the reported intervals have not been determined, historical sampling data cited by the company has not been fully verified, and the company paid US$150,000 to Emerging Markets Consulting for three months of investor awareness services beginning September 29, 2026. Connect Biopharma is a clinical-stage company with no approved products; rademikibart is investigational; the COPD results are preliminary topline Phase 2 data; the Week 4 FEV1 result was not statistically significant (p=0.1607) and the stated key secondary endpoint of Week 1 FEV1 was not reported in the topline release; the company reported $31.5 million in cash and short-term investments at June 30, 2026 and has not announced funding for a Phase 3 program. The Sangoma Technologies transaction is subject to shareholder approval by two-thirds of votes cast and a majority-of-the-minority vote, court approval, and regulatory approvals, and may not close; part of the consideration is paid in BRC Group Holdings stock, so its value will change with BRC’s share price; a US$5,397,000 termination fee applies in specified circumstances. Sigma Lithium’s legal and regulatory situation in Brazil was unresolved as of October 1, 2026 and may have changed since publication. These are speculative investments carrying significant risk including potential total loss of capital. Digital assets are highly volatile. Coverage on aktiego.com is provided for informational and educational purposes only. aktiego.com is not a registered investment advisor. Nothing in this article constitutes financial, investment, or professional advice. Readers are encouraged to conduct their own due diligence and consult a qualified financial advisor before making
